Recarbrio Effective for Hospital-Acquired Bacterial Pneumonia Recarbrio Effective for Hospital-Acquired Bacterial Pneumonia

Recarbrio is noninferior to piperacillin/tazobactam for treating adults with hospital-acquired or ventilator-associated bacterial pneumonia, according to results from the RESTORE-IMI 2 trial.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news